+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pneumonia Diagnostics Kit Market by Product (Culture Tests, Imaging Systems, Molecular Diagnostics), Technology (Immunoassay, LAMP, Next-Gen Sequencing), End User, Distribution Channel, Sample Type, Price Range - Global Forecast 2025-2030- Product Image
Pneumonia Diagnostics Kit Market by Product (Culture Tests, Imaging Systems, Molecular Diagnostics), Technology (Immunoassay, LAMP, Next-Gen Sequencing), End User, Distribution Channel, Sample Type, Price Range - Global Forecast 2025-2030- Product Image
New

Pneumonia Diagnostics Kit Market by Product (Culture Tests, Imaging Systems, Molecular Diagnostics), Technology (Immunoassay, LAMP, Next-Gen Sequencing), End User, Distribution Channel, Sample Type, Price Range - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6134230
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The complexity of diagnosing pneumonia demands a refined approach that integrates advanced technologies, robust clinical protocols, and a patient-centric focus. This executive summary initiates an exploration into the pivotal factors reshaping pneumonia diagnostics, emphasizing how innovation and collaboration are accelerating detection accuracy and driving transformative improvements in patient care.

By examining the convergence of molecular techniques, imaging enhancements, and streamlined laboratory workflows, this study highlights the critical intersection of precision medicine and practical clinical application. Furthermore, it underscores the necessity for diagnostic platforms that can rapidly adapt to emerging pathogens and evolving healthcare environments. As we proceed, the narrative will weave together market dynamics, regulatory evolutions, and technology trends to provide a cohesive view of the forces guiding the future of pneumonia diagnostics.

Unveiling Key Shifts Reshaping Pneumonia Diagnostic Technologies and Practices to Navigate Rapid Technological Advancements and Evolving Clinical Demands

Rapid advances in laboratory automation and point-of-care technologies have fundamentally altered the framework for pneumonia diagnostics. High-throughput molecular assays, particularly those harnessing next-generation sequencing and LAMP methodologies, are delivering pathogen identification at unprecedented speeds. Simultaneously, enhancements in imaging modalities-ranging from low-dose computed tomography to AI-powered X-ray interpretation-are improving the precision of radiological evaluations and enabling earlier intervention.

In parallel, the integration of serological platforms that operate through CLIA, ELISA, and lateral flow immunoassays has expanded the diagnostic arsenal, offering complementary insights into host immune response. This multifaceted evolution reflects a shift toward hybrid diagnostic strategies that balance sensitivity, specificity, and cost-effectiveness. Consequently, healthcare providers are better equipped to tailor treatment regimens, track antimicrobial resistance trends, and optimize resource allocation within diverse care settings.

Assessing the Far-Reaching Effects of Proposed 2025 United States Tariffs on Pneumonia Diagnostic Supply Chains and Market Accessibility

The introduction of proposed tariffs on imported diagnostic components in 2025 represents a significant inflection point for supply chain stability and cost structures. Essential reagents used in polymerase chain reaction assays and specialized consumables for molecular rapid test kits may face heightened duties, potentially increasing per-test expenditure. This scenario underscores the importance of strategic sourcing and the potential need for domestic manufacturing partnerships to mitigate pricing pressures.

Moreover, anticipated adjustments in the cost basis for imaging hardware components could influence procurement cycles for CT scan modules and ultrasound transducers. Providers may need to evaluate total cost of ownership more rigorously, factoring in maintenance agreements and upgrade pathways. Ultimately, these tariff-driven dynamics will demand collaborative dialogue between suppliers, laboratories, and regulatory agencies to safeguard accessibility and maintain continuity in critical pneumonia diagnostic services.

Deep Dive into Product, Technology, End User, Distribution Channel, Sample Type, and Price Range Segmentations Shaping Pneumonia Diagnostics Adoption

Analysis of the pneumonia diagnostics landscape through the lens of product segmentation reveals a diverse array of platforms. Culture-based methods remain foundational, with blood culture and sputum culture serving as critical tools for pathogen isolation. Imaging solutions that encompass computed tomography scans, ultrasound systems, and chest X-ray technologies continue to deliver essential anatomic and functional information. Molecular diagnostics comprise multiple pillars, including loop-mediated isothermal amplification techniques, high-throughput next-generation sequencing workflows, and conventional polymerase chain reaction assays. Rapid testing innovations span antigen-based test kits alongside accelerated molecular rapid diagnostics, while serological approaches utilize chemiluminescence immunoassays, enzyme-linked immunosorbent assays, and lateral flow immunoassays to elucidate immune status and historical exposure.

Complementing the product view, the technology-oriented perspective highlights immunoassay methodologies with CLIA, ELISA, and lateral flow platforms at the forefront. Next-generation sequencing strategies leverage leading instrumentation from Illumina, Ion Torrent, and PacBio to decode complex microbial communities. Polymerase chain reaction configurations further subdivide into real-time and digital formats to enhance quantification precision. Beyond technology, diagnostic utilization varies across ambulatory care centers, outpatient clinics, high-volume diagnostic laboratories, and acute-care hospitals. Distribution frameworks range from direct engagement with end users to partnerships with specialized distributors and expansion into digital commerce channels. Sample types span bronchoalveolar lavage fluid, peripheral blood, pleural effusions, and sputum specimens, each presenting unique processing requirements. Finally, price differentiation, whether positioned in lower, medium, or high tiers, shapes adoption patterns based on budgetary constraints and value propositions.

Examining Regional Dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific to Uncover Pneumonia Diagnostic Market Drivers

Regional market dynamics are influenced by varied healthcare infrastructures, regulatory frameworks, and disease prevalence patterns across the Americas, Europe Middle East & Africa, and the Asia-Pacific. In the Americas, the emphasis on outpatient diagnostics and accelerated molecular workflows is driven by high demand for rapid turnaround times. Healthcare providers in North America are investing in advanced imaging suites and integrated laboratory-information systems to facilitate streamlined diagnostic pathways.

Across Europe, the Middle East, and Africa, diverse regulatory environments and resource allocations necessitate adaptable diagnostic solutions. High-income regions prioritize high-sensitivity molecular assays and research-grade sequencing platforms, while emerging markets are increasingly adopting cost-effective rapid test kits and point-of-care imaging modules to bridge accessibility gaps.

In the Asia-Pacific, robust manufacturing capacity and government initiatives to bolster diagnostic infrastructure are energizing market expansion. Collaborative research consortia and public-private partnerships are accelerating the validation of novel biomarkers, with a focus on scalable testing strategies that address both urban and rural healthcare challenges. This confluence of investment, policy support, and technological innovation is positioning the Asia-Pacific as a pivotal arena for pneumonia diagnostics advancement.

Exploring Strategies and Competitive Positioning of Leading Innovators Driving Progress in Pneumonia Diagnostic Solutions Worldwide

Leading companies in the pneumonia diagnostics field are leveraging strategic alliances, product diversification, and platform integration to consolidate their competitive positions. Innovators with comprehensive portfolios spanning molecular assays, immunoassays, and imaging instruments are capitalizing on cross-platform synergies to deliver end-to-end diagnostic workflows. Several organizations have focused R&D investments on next-generation sequencing applications for multiplex pathogen detection, while others have advanced portable imaging devices that integrate artificial intelligence for real-time evaluation.

Collaborations between established diagnostic firms and emerging biotechnology players are fostering knowledge exchange and expediting time-to-market for breakthrough assays. Intellectual property acquisitions and licensing agreements are further expanding the technological frontiers, particularly in the realm of isothermal amplification and digital diagnostics. Importantly, robust service infrastructures-such as remote monitoring, predictive maintenance, and training programs-are differentiating leaders by ensuring sustained performance and user adoption. These strategic initiatives collectively underscore the imperative for continuous innovation and ecosystem engagement.

Strategic Recommendations for Healthcare Stakeholders to Optimize Pneumonia Diagnostics Performance and Deliver Enhanced Patient Outcomes

Industry leaders should prioritize the development of modular diagnostic ecosystems that integrate molecular, serological, and imaging data to enable comprehensive clinical decision support. By investing in interoperable software platforms, stakeholders can facilitate seamless data exchange across laboratory, radiology, and electronic health record systems. Furthermore, establishing cross-disciplinary training programs for clinical and laboratory teams will enhance diagnostic proficiency and foster standardized best practices.

To mitigate tariff-related cost challenges, organizations can explore localized manufacturing partnerships and collaborative procurement models. Engaging with policymakers to articulate the public-health implications of elevated trade barriers will help cultivate a more balanced regulatory environment. Additionally, targeted investment in next-generation point-of-care devices designed for resource-limited settings will expand market reach while addressing unmet diagnostic needs. Ultimately, a proactive, ecosystem-oriented strategy will empower industry leaders to navigate complexity, drive sustainable growth, and deliver superior patient outcomes.

Comprehensive Research Methodology Integrating Quantitative Analysis, Qualitative Interviews, and Rigorous Validation to Ensure Data Integrity

This research employed a blended methodology that combined quantitative data aggregation with qualitative stakeholder insights to ensure comprehensive coverage and data integrity. Primary data collection included in-depth interviews with clinical microbiologists, infectious disease specialists, procurement managers, and policymakers across multiple regions. Concurrently, secondary sources such as academic journals, regulatory filings, and industry publications provided foundational context and historical benchmarks.

To validate findings, cross-referencing techniques were applied, including triangulation of proprietary clinical trial outcomes with real-world evidence captured through laboratory information management systems. Advanced data-analysis tools supported segmentation modeling and trend identification, while peer review sessions with subject-matter experts helped refine assumptions and interpret nuanced market dynamics. Ethical considerations and data-privacy standards were rigorously upheld throughout the research lifecycle, ensuring that the resulting insights are both reliable and actionable.

Synthesizing Critical Insights to Illuminate the Future Path of Pneumonia Diagnostics and Inform Strategic Decision Making in Healthcare

The trajectory of pneumonia diagnostics is shaped by a confluence of technological, regulatory, and economic forces. Innovations in molecular assays, imaging enhancements, and serological platforms are converging to enable faster, more precise diagnoses, while strategic collaborations and flexible commercialization models are redefining market engagement.

As challenges like trade policy shifts and resource variability persist, the sector’s resilience will depend on adaptive strategies that balance cost, performance, and accessibility. By synthesizing product diversifications, regional nuances, and competitive maneuvers, this executive summary illuminates the critical drivers and potential inflection points that will determine the future direction of pneumonia diagnostics. Stakeholders equipped with these insights will be well-positioned to make informed decisions and capitalize on emerging opportunities.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product
    • Culture Tests
      • Blood Culture
      • Sputum Culture
    • Imaging Systems
      • CT Scan
      • Ultrasound
      • X-Ray
    • Molecular Diagnostics
      • LAMP
      • Next-Gen Sequencing
      • PCR
    • Rapid Test Kits
      • Antigen Test Kits
      • Molecular Rapid Test Kits
    • Serological Tests
      • CLIA
      • ELISA
      • LFA
  • Technology
    • Immunoassay
      • CLIA
      • ELISA
      • LFA
    • LAMP
    • Next-Gen Sequencing
      • Illumina
      • Ion Torrent
      • PacBio
    • PCR
      • Digital PCR
      • Real-Time PCR
  • End User
    • Ambulatory Care Centers
    • Clinics
    • Diagnostic Laboratories
    • Hospitals
  • Distribution Channel
    • Direct Sales
    • Distributors
    • Online Platforms
  • Sample Type
    • BAL
    • Blood
    • Pleural Fluid
    • Sputum
  • Price Range
    • High
    • Low
    • Medium
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Roche Diagnostics International AG
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Becton, Dickinson and Company
  • Hologic, Inc.
  • QIAGEN N.V.
  • PerkinElmer, Inc.
  • Bio-Rad Laboratories, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Implementation of CRISPR-based assays to enable multiplex detection of pneumonia pathogens within 30 minutes
5.2. Growing adoption of point-of-care molecular tests offering real-time detection of antibiotic resistance markers in pneumonia
5.3. Increasing integration of AI-driven image analysis with digital chest X-rays for automated pneumonia diagnosis in resource-limited settings
5.4. Expansion of next-generation sequencing panels for comprehensive pathogen identification and strain-level typing in pneumonia diagnostics
5.5. Development of portable microfluidic platforms for simultaneous detection of bacterial and viral pneumonia agents in field settings
5.6. Rising demand for automated immunoassay cartridges enabling high-throughput serological screening of pneumonia biomarkers in clinical labs
5.7. Emergence of telehealth-connected diagnostic devices allowing remote monitoring of pneumonia progression through digital data transmission
5.8. Advancements in biosensor technology leveraging nanomaterials to improve sensitivity and specificity of pneumonia antigen detection
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pneumonia Diagnostics Kit Market, by Product
8.1. Introduction
8.2. Culture Tests
8.2.1. Blood Culture
8.2.2. Sputum Culture
8.3. Imaging Systems
8.3.1. CT Scan
8.3.2. Ultrasound
8.3.3. X-Ray
8.4. Molecular Diagnostics
8.4.1. LAMP
8.4.2. Next-Gen Sequencing
8.4.3. PCR
8.5. Rapid Test Kits
8.5.1. Antigen Test Kits
8.5.2. Molecular Rapid Test Kits
8.6. Serological Tests
8.6.1. CLIA
8.6.2. ELISA
8.6.3. LFA
9. Pneumonia Diagnostics Kit Market, by Technology
9.1. Introduction
9.2. Immunoassay
9.2.1. CLIA
9.2.2. ELISA
9.2.3. LFA
9.3. LAMP
9.4. Next-Gen Sequencing
9.4.1. Illumina
9.4.2. Ion Torrent
9.4.3. PacBio
9.5. PCR
9.5.1. Digital PCR
9.5.2. Real-Time PCR
10. Pneumonia Diagnostics Kit Market, by End User
10.1. Introduction
10.2. Ambulatory Care Centers
10.3. Clinics
10.4. Diagnostic Laboratories
10.5. Hospitals
11. Pneumonia Diagnostics Kit Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributors
11.4. Online Platforms
12. Pneumonia Diagnostics Kit Market, by Sample Type
12.1. Introduction
12.2. BAL
12.3. Blood
12.4. Pleural Fluid
12.5. Sputum
13. Pneumonia Diagnostics Kit Market, by Price Range
13.1. Introduction
13.2. High
13.3. Low
13.4. Medium
14. Americas Pneumonia Diagnostics Kit Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Pneumonia Diagnostics Kit Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Pneumonia Diagnostics Kit Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Roche Diagnostics International AG
17.3.2. Abbott Laboratories
17.3.3. Siemens Healthineers AG
17.3.4. Thermo Fisher Scientific Inc.
17.3.5. bioMérieux SA
17.3.6. Becton, Dickinson and Company
17.3.7. Hologic, Inc.
17.3.8. QIAGEN N.V.
17.3.9. PerkinElmer, Inc.
17.3.10. Bio-Rad Laboratories, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. PNEUMONIA DIAGNOSTICS KIT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRICE RANGE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRICE RANGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. PNEUMONIA DIAGNOSTICS KIT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. PNEUMONIA DIAGNOSTICS KIT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. PNEUMONIA DIAGNOSTICS KIT MARKET: RESEARCHAI
FIGURE 28. PNEUMONIA DIAGNOSTICS KIT MARKET: RESEARCHSTATISTICS
FIGURE 29. PNEUMONIA DIAGNOSTICS KIT MARKET: RESEARCHCONTACTS
FIGURE 30. PNEUMONIA DIAGNOSTICS KIT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PNEUMONIA DIAGNOSTICS KIT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY CULTURE TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY CULTURE TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY BLOOD CULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY BLOOD CULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SPUTUM CULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SPUTUM CULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY CULTURE TESTS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY CULTURE TESTS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY CT SCAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY CT SCAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY X-RAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY X-RAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY LAMP, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY LAMP, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY NEXT-GEN SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY NEXT-GEN SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY ANTIGEN TEST KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY ANTIGEN TEST KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR RAPID TEST KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR RAPID TEST KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST KITS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST KITS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SEROLOGICAL TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SEROLOGICAL TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY CLIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY CLIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY LFA, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY LFA, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SEROLOGICAL TESTS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY CLIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY CLIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY LFA, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY LFA, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY LAMP, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY LAMP, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY NEXT-GEN SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY NEXT-GEN SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY ILLUMINA, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY ILLUMINA, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY ION TORRENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY ION TORRENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PACBIO, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PACBIO, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY NEXT-GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY BAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY BAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PLEURAL FLUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PLEURAL FLUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SPUTUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SPUTUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRICE RANGE, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRICE RANGE, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY HIGH, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY HIGH, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY LOW, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY LOW, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY MEDIUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY MEDIUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY CULTURE TESTS, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY CULTURE TESTS, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST KITS, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST KITS, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SEROLOGICAL TESTS, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY NEXT-GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRICE RANGE, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRICE RANGE, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY CULTURE TESTS, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY CULTURE TESTS, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST KITS, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST KITS, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SEROLOGICAL TESTS, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY NEXT-GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRICE RANGE, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRICE RANGE, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 185. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 186. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 187. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY CULTURE TESTS, 2018-2024 (USD MILLION)
TABLE 188. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY CULTURE TESTS, 2025-2030 (USD MILLION)
TABLE 189. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 190. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 191. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 192. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 193. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST KITS, 2018-2024 (USD MILLION)
TABLE 194. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST KITS, 2025-2030 (USD MILLION)
TABLE 195. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2024 (USD MILLION)
TABLE 196. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SEROLOGICAL TESTS, 2025-2030 (USD MILLION)
TABLE 197. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 198. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 199. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 200. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 201. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 202. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY NEXT-GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 203. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 204. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 205. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 210. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 211. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRICE RANGE, 2018-2024 (USD MILLION)
TABLE 212. CANADA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRICE RANGE, 2025-2030 (USD MILLION)
TABLE 213. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 214. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 215. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY CULTURE TESTS, 2018-2024 (USD MILLION)
TABLE 216. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY CULTURE TESTS, 2025-2030 (USD MILLION)
TABLE 217. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 218. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 219. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 220. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 221. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST KITS, 2018-2024 (USD MILLION)
TABLE 222. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST KITS, 2025-2030 (USD MILLION)
TABLE 223. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2024 (USD MILLION)
TABLE 224. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SEROLOGICAL TESTS, 2025-2030 (USD MILLION)
TABLE 225. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 226. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 227. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 228. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 229. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 230. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY NEXT-GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 231. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 232. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 233. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 238. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 239. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRICE RANGE, 2018-2024 (USD MILLION)
TABLE 240. MEXICO PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRICE RANGE, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY CULTURE TESTS, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY CULTURE TESTS, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST KITS, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST KITS, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SEROLOGICAL TESTS, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY NEXT-GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRICE RANGE, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRICE RANGE, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY CULTURE TESTS, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY CULTURE TESTS, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST KITS, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST KITS, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SEROLOGICAL TESTS, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY NEXT-GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRICE RANGE, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRICE RANGE, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY CULTURE TESTS, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY CULTURE TESTS, 2025-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMAGING SYSTEMS, 2025-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST KITS, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST KITS, 2025-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2024 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY SEROLOGICAL TESTS, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY NEXT-GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. EUR

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Pneumonia Diagnostics Kit market report include:
  • Roche Diagnostics International AG
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Becton, Dickinson and Company
  • Hologic, Inc.
  • QIAGEN N.V.
  • PerkinElmer, Inc.
  • Bio-Rad Laboratories, Inc.

Related Topics

Related Reports

Mycoplasma Pneumonia Test kits Market by Product Type (Culture Based Test Kits, Molecular Test Kits, Point Of Care Test Kits), Sample Type (Blood Samples, Respiratory Specimens), End User, Distribution Channel, Technology - Global Forecast 2025-2030 - Product Image

Mycoplasma Pneumonia Test kits Market by Product Type (Culture Based Test Kits, Molecular Test Kits, Point Of Care Test Kits), Sample Type (Blood Samples, Respiratory Specimens), End User, Distribution Channel, Technology - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Mycoplasma Pneumonia IgM Antibody Test Kits Market by Test Type, End User, Distribution Channel, Technology, Sample Type, Format - Global Forecast 2025-2030 - Product Image

Mycoplasma Pneumonia IgM Antibody Test Kits Market by Test Type, End User, Distribution Channel, Technology, Sample Type, Format - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Pneumonia Testing Market by Test Type (Culture, Immunoassay Test, Molecular Test), Technology Platform (Digital Radiography, Isothermal Amplification, Lateral Flow Assay), End User, Sample Type, Distribution Channel - Global Forecast 2025-2030 - Product Image

Pneumonia Testing Market by Test Type (Culture, Immunoassay Test, Molecular Test), Technology Platform (Digital Radiography, Isothermal Amplification, Lateral Flow Assay), End User, Sample Type, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Infectious Disease Diagnostic Market by Product (Instruments, Reagents & Kits, Software), Sample Type (Blood, Stool, Swab), Technology, Testing Type, Disease Type, End-User - Global Forecast 2025-2030 - Product Image

Infectious Disease Diagnostic Market by Product (Instruments, Reagents & Kits, Software), Sample Type (Blood, Stool, Swab), Technology, Testing Type, Disease Type, End-User - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Pneumonia Testing Market Analysis & Forecast to 2023-2033: Market By Type; By Product; By Method; By Technology; By End-user; and By Region - Product Image

Pneumonia Testing Market Analysis & Forecast to 2023-2033: Market By Type; By Product; By Method; By Technology; By End-user; and By Region

  • Report
  • 145 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.